Poslední aktualizace :
03/05/2024
Infostab
Seznamy
Seznamy shrnutí
Hledat kompatibility
Tabulka kompatibility správy Y
Odkazy
Výzkumné týmy
Valistab
Plakát
Připojení
Sponzoři
Autor
Uživatelská příručka
Newsletter
Výzkumné týmy - University Hospital Pontchaillou, Department of Pharmacy
University Hospital Pontchaillou, Department of Pharmacy
Rennes
gilles.dollo@chu-rennes.fr
Odkazy
(8)
1
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
Adoum A, Le P., Faisant S, Legendre P, Lester MA, Boivin PN. (anissa.adoum@gmail.com)
Pharmaceutical Technology in Hospital Pharmacy -
2022
- 2022; 7(1): 20220005
2
Développement de formulations buvables de vinorelbine à usage pédiatrique.
Macqueron L, Régnier L, Robinet P, Leroy AM, Lester MA, Boivin PN, Le Corre P. (pierre-nicolas.boivin@chu-rennes.fr)
GERPAC Congrès - octobre 2022 -
2022
-
3
Physicochemical stability of compounded midazolam capsules over a one-year storage period.
Boivin P-N, Legendre P, Bonnaure A-C, M-A. (pierre-nicolas.boivin@chu-rennes.fr)
Pharmaceutical Technology in Hospital Pharmacy -
2020
-
4
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4.
Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N. (anne-claire.bonnaure@hotmail.com)
Pharmaceutical Technology in Hospital Pharmacy -
2018
-
5
Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4.
Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N. (romain.bellay@hotmail.fr)
Pharmaceutical Technology in Hospital Pharmacy -
2018
- ;3,1:31-37
6
Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique.
Barbazan C, Le Daré, Lester M-A, Boivin P-N. ()
11ème Recontres Convergences Santé Hôpital -
2016
-
7
Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution
Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G. (gilles.dollo@chu-rennes.fr)
Ann Pharm Fr -
2015
- ; 73, 1: 31-36.
8
Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers.
Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR. ()
J Pharm Clin -
1992
- ; 11: 285-295.
Molekuly studoval
(8)
Amiodarone hydrochloride
Cloxacilline
Methotrexate sodium
Midazolam hydrochloride
Nitrendipine
Phenylephrine hydrochloride
Prednisone
Vinorelbine
Mentions Légales
